GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » 3-Year ROIIC %

Kindstar Globalgene Technology (HKSE:09960) 3-Year ROIIC % : -16.70% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Kindstar Globalgene Technology's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was -16.70%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Kindstar Globalgene Technology's 3-Year ROIIC % or its related term are showing as below:

HKSE:09960's 3-Year ROIIC % is ranked worse than
58.82% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.94 vs HKSE:09960: -16.70

Kindstar Globalgene Technology 3-Year ROIIC % Historical Data

The historical data trend for Kindstar Globalgene Technology's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology 3-Year ROIIC % Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial - - -5.90 -8.15 -16.70

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -8.15 - -16.70 -

Competitive Comparison of Kindstar Globalgene Technology's 3-Year ROIIC %

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's 3-Year ROIIC % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's 3-Year ROIIC % falls into.



Kindstar Globalgene Technology 3-Year ROIIC % Calculation

Kindstar Globalgene Technology's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -39.0817502 (Dec. 2023) - 111.1692356 (Dec. 2020) )/( 1400.404 (Dec. 2023) - 500.764 (Dec. 2020) )
=-150.2509858/899.64
=-16.70%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Kindstar Globalgene Technology  (HKSE:09960) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Kindstar Globalgene Technology 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.
Executives
Jackson Hole Trust Company
Huang Bo
Kernelstar Limited 2301 Trustee
Kastle Limited 2301 Trustee
Guo Gui-rong 2202 Interest of your spouse
Huang Shiang 2101 Beneficial owner
Huang Zuie-chin 2101 Beneficial owner
Tu Zanbing
Chan Tan Ching Fen 2307 Founder of a discretionary trust who can infl
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Cpechina Fund Iii, L.p. 2201 Interest of corporation controlled by you
Cpe Holdings Limited 2201 Interest of corporation controlled by you
Cpe Holdings International Limited 2201 Interest of corporation controlled by you
Cpe Funds Iii Limited 2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited 2101 Beneficial owner

Kindstar Globalgene Technology Headlines

No Headlines